Kong Pengfei, Wu Ruiyan, Lan Yadong, He Wenzhuo, Yang Chenlu, Yin Chenxi, Yang Qiong, Jiang Chang, Xu Dazhi, Xia Liangping
State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, 510000, PR China.
Department of the VIP region, Sun Yat-sen University Cancer Centre, Guangzhou, 510000, PR China.
J Cancer. 2017 Sep 16;8(16):3296-3308. doi: 10.7150/jca.19810. eCollection 2017.
Microsatellites instability (MSI) is a risk factor for multiple primary cancers (MPCs). However, a variety of studies focused on the risk in the hereditary non-polyposis colorectal cancer (HNPCC) not the sporadic colorectal cancer (CRC) patients. The aim of this meta-analysis was to comprehensive overview and quantitative summary the association between MSI and risk of MPCs. A comprehensive literature search in MEDLINE, EMBASE, Web of science, ScienceDirect, Weily and OVID was conducted. Up to May 2016, we identified 22 observational studies. We calculated the summary relative risk (RR) for the risk of MPCs in MSI patients compared with microsatellites stability (MSS) patients using fixed- or random-effects models. The RR of the association between mismatch-repair gene (MMR) genotype and MPCs was 2.59 (95% confidence interval [CI], 2.06 to 3.27); the RR was 2.14 (95% CI, 1.78 to 2.57) for sporadic CRC and 5.59 (95% CI, 2.69 to 11.59) for HNPCC for the MSI versus MSS category. The subgroup analyses showed different mutant gene, mutant locus, and mutant level of MMR with different influence on the patients susceptible to MPCs. In addition, MSI genotype increase the risk of MPC was not associated with an apparently specific in regard to site, timing, age and detection method. In conclusion, this meta-analysis indicates that MSI is associated with an increased risk of MPCs both in the HNPCC and sporadic CRC patients. Our findings will form the backbone of the treatment for MSI genotype may be an important valuable strategy for MPCs prevention.
微卫星不稳定性(MSI)是多种原发性癌症(MPC)的一个风险因素。然而,各种研究关注的是遗传性非息肉病性结直肠癌(HNPCC)患者而非散发性结直肠癌(CRC)患者的风险。本荟萃分析的目的是全面概述并定量总结MSI与MPC风险之间的关联。我们在MEDLINE、EMBASE、科学网、ScienceDirect、威立和OVID数据库中进行了全面的文献检索。截至2016年5月,我们共识别出22项观察性研究。我们使用固定效应或随机效应模型计算了MSI患者与微卫星稳定(MSS)患者相比发生MPC风险的汇总相对风险(RR)。错配修复基因(MMR)基因型与MPC之间关联的RR为2.59(95%置信区间[CI],2.06至3.27);MSI与MSS分类中,散发性CRC的RR为2.14(95%CI,1.78至2.57),HNPCC的RR为5.59(95%CI,2.69至11.59)。亚组分析显示,MMR的不同突变基因、突变位点和突变水平对易患MPC的患者有不同影响。此外,MSI基因型增加MPC风险与部位、时间、年龄和检测方法方面无明显特异性相关。总之,本荟萃分析表明,MSI与HNPCC和散发性CRC患者发生MPC的风险增加相关。我们的研究结果将构成治疗的基础,因为MSI基因型可能是预防MPC的一项重要且有价值的策略。